Global Healthcare Microfluidics 麻豆原创 Research Report 2023

Publication ID:

PB502234556

Publication Date:

February 22, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The field of microfluidics uses microfabrication to create miniaturized devices to handle fluids. The field of microfluidics has four parents: molecular analysis, biodefence, molecular biology and microelectronics. Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (glucose and lactate assays), DNA analysis (polymerase chain reaction and high-throughput sequencing), and proteomics.
Highlights
The global Healthcare Microfluidics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Healthcare Microfluidics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Healthcare Microfluidics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Healthcare Microfluidics include Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer and Thermo Fisher Scientific, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Healthcare Microfluidics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Microfluidics.
The Healthcare Microfluidics market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Healthcare Microfluidics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Healthcare Microfluidics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott Laboratories
Agilent Technologies, Inc.
BD
Bio-Rad Laboratories
Danaher Corporation
Roche
IDEX Corporation
PerkinElmer
Thermo Fisher Scientific
Segment by Type
Glass Based
Polymer Based
Silicon Based
Others
Segment by Application
麻豆原创care
Hospitals
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Healthcare Microfluidics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Healthcare Microfluidics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Healthcare Microfluidics 麻豆原创 Overview
1.1 Product Overview and Scope of Healthcare Microfluidics
1.2 Healthcare Microfluidics Segment by Type
1.2.1 Global Healthcare Microfluidics 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Glass Based
1.2.3 Polymer Based
1.2.4 Silicon Based
1.2.5 Others
1.3 Healthcare Microfluidics Segment by Application
1.3.1 Global Healthcare Microfluidics 麻豆原创 Value by Application: (2023-2029)
1.3.2 麻豆原创care
1.3.3 Hospitals
1.3.4 Others
1.4 Global Healthcare Microfluidics 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Healthcare Microfluidics Revenue 2018-2029
1.4.2 Global Healthcare Microfluidics Sales 2018-2029
1.4.3 Global Healthcare Microfluidics 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Healthcare Microfluidics 麻豆原创 Competition by Manufacturers
2.1 Global Healthcare Microfluidics Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Healthcare Microfluidics Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Healthcare Microfluidics Average Price by Manufacturers (2018-2023)
2.4 Global Healthcare Microfluidics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Healthcare Microfluidics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Healthcare Microfluidics, Product Type & Application
2.7 Healthcare Microfluidics 麻豆原创 Competitive Situation and Trends
2.7.1 Healthcare Microfluidics 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Healthcare Microfluidics Players 麻豆原创 Share by Revenue
2.7.3 Global Healthcare Microfluidics 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Healthcare Microfluidics Retrospective 麻豆原创 Scenario by Region
3.1 Global Healthcare Microfluidics 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Healthcare Microfluidics Global Healthcare Microfluidics Sales by Region: 2018-2029
3.2.1 Global Healthcare Microfluidics Sales by Region: 2018-2023
3.2.2 Global Healthcare Microfluidics Sales by Region: 2024-2029
3.3 Global Healthcare Microfluidics Global Healthcare Microfluidics Revenue by Region: 2018-2029
3.3.1 Global Healthcare Microfluidics Revenue by Region: 2018-2023
3.3.2 Global Healthcare Microfluidics Revenue by Region: 2024-2029
3.4 North America Healthcare Microfluidics 麻豆原创 Facts & Figures by Country
3.4.1 North America Healthcare Microfluidics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Healthcare Microfluidics Sales by Country (2018-2029)
3.4.3 North America Healthcare Microfluidics Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Healthcare Microfluidics 麻豆原创 Facts & Figures by Country
3.5.1 Europe Healthcare Microfluidics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Healthcare Microfluidics Sales by Country (2018-2029)
3.5.3 Europe Healthcare Microfluidics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Healthcare Microfluidics 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Healthcare Microfluidics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Healthcare Microfluidics Sales by Country (2018-2029)
3.6.3 Asia Pacific Healthcare Microfluidics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Healthcare Microfluidics 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Healthcare Microfluidics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Healthcare Microfluidics Sales by Country (2018-2029)
3.7.3 Latin America Healthcare Microfluidics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Healthcare Microfluidics 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Healthcare Microfluidics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Healthcare Microfluidics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Healthcare Microfluidics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Healthcare Microfluidics Sales by Type (2018-2029)
4.1.1 Global Healthcare Microfluidics Sales by Type (2018-2023)
4.1.2 Global Healthcare Microfluidics Sales by Type (2024-2029)
4.1.3 Global Healthcare Microfluidics Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Healthcare Microfluidics Revenue by Type (2018-2029)
4.2.1 Global Healthcare Microfluidics Revenue by Type (2018-2023)
4.2.2 Global Healthcare Microfluidics Revenue by Type (2024-2029)
4.2.3 Global Healthcare Microfluidics Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Healthcare Microfluidics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Healthcare Microfluidics Sales by Application (2018-2029)
5.1.1 Global Healthcare Microfluidics Sales by Application (2018-2023)
5.1.2 Global Healthcare Microfluidics Sales by Application (2024-2029)
5.1.3 Global Healthcare Microfluidics Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Healthcare Microfluidics Revenue by Application (2018-2029)
5.2.1 Global Healthcare Microfluidics Revenue by Application (2018-2023)
5.2.2 Global Healthcare Microfluidics Revenue by Application (2024-2029)
5.2.3 Global Healthcare Microfluidics Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Healthcare Microfluidics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Healthcare Microfluidics Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Agilent Technologies, Inc.
6.2.1 Agilent Technologies, Inc. Corporation Information
6.2.2 Agilent Technologies, Inc. Description and Business Overview
6.2.3 Agilent Technologies, Inc. Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Agilent Technologies, Inc. Healthcare Microfluidics Product Portfolio
6.2.5 Agilent Technologies, Inc. Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Healthcare Microfluidics Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Bio-Rad Laboratories
6.4.1 Bio-Rad Laboratories Corporation Information
6.4.2 Bio-Rad Laboratories Description and Business Overview
6.4.3 Bio-Rad Laboratories Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Rad Laboratories Healthcare Microfluidics Product Portfolio
6.4.5 Bio-Rad Laboratories Recent Developments/Updates
6.5 Danaher Corporation
6.5.1 Danaher Corporation Corporation Information
6.5.2 Danaher Corporation Description and Business Overview
6.5.3 Danaher Corporation Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Danaher Corporation Healthcare Microfluidics Product Portfolio
6.5.5 Danaher Corporation Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Roche Healthcare Microfluidics Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 IDEX Corporation
6.6.1 IDEX Corporation Corporation Information
6.6.2 IDEX Corporation Description and Business Overview
6.6.3 IDEX Corporation Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 IDEX Corporation Healthcare Microfluidics Product Portfolio
6.7.5 IDEX Corporation Recent Developments/Updates
6.8 PerkinElmer
6.8.1 PerkinElmer Corporation Information
6.8.2 PerkinElmer Description and Business Overview
6.8.3 PerkinElmer Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 PerkinElmer Healthcare Microfluidics Product Portfolio
6.8.5 PerkinElmer Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Corporation Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific Healthcare Microfluidics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Thermo Fisher Scientific Healthcare Microfluidics Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Healthcare Microfluidics Industry Chain Analysis
7.2 Healthcare Microfluidics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Healthcare Microfluidics Production Mode & Process
7.4 Healthcare Microfluidics Sales and 麻豆原创ing
7.4.1 Healthcare Microfluidics Sales Channels
7.4.2 Healthcare Microfluidics Distributors
7.5 Healthcare Microfluidics Customers
8 Healthcare Microfluidics 麻豆原创 Dynamics
8.1 Healthcare Microfluidics Industry Trends
8.2 Healthcare Microfluidics 麻豆原创 Drivers
8.3 Healthcare Microfluidics 麻豆原创 Challenges
8.4 Healthcare Microfluidics 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott Laboratories
Agilent Technologies, Inc.
BD
Bio-Rad Laboratories
Danaher Corporation
Roche
IDEX Corporation
PerkinElmer
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.